Hamburg, Germany

Anke Heuser


 

Average Co-Inventor Count = 13.6

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Hamburg, DE (2012 - 2015)
  • Constance, DE (2016)

Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Anke Heuser: Innovator in Pharmaceutical Chemistry

Introduction

Anke Heuser is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 5 patents to her name, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are innovative compounds such as pyrazolone-derivatives, which serve as effective inhibitors of the type 4 phosphodiesterase (PDE-4). One notable patent describes a compound, 1-(2-{4-[3-(3,4-dimethoxyphenyl)-4,4-dimethyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione, which is particularly useful in treating conditions like psoriasis and atopic dermatitis.

Career Highlights

Anke has worked with reputable companies in the pharmaceutical industry, including Takeda GmbH and Nycomed GmbH. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in drug development.

Collaborations

Throughout her career, Anke has collaborated with notable colleagues, including Beate Schmidt and Armin Hatzelmann. These partnerships have facilitated the exchange of ideas and fostered innovation in their respective fields.

Conclusion

Anke Heuser's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a leading inventor in the industry. Her work continues to impact the development of effective treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…